What does CUSIP G6829J107 represent in this 13F holders report?

CUSIP G6829J107 is the security identifier for OCDX - ORTHO CLINICAL DIAGNOSTICS H - ORD SHS used to aggregate holder disclosures.

How many institutions held OCDX - ORTHO CLINICAL DIAGNOSTICS H - ORD SHS in Q4 2021?

160 institutional investors reported OCDX - ORTHO CLINICAL DIAGNOSTICS H - ORD SHS for Q4 2021. Use the holders table for investor-level position and value details.

ORTHO CLINICAL DIAGNOSTICS H - ORD SHS (OCDX)

CUSIP: G6829J107

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / ORD SHS
Total 13F shares: 234,081,450
Share change: +234,705
Total reported value: $5,006,584,920
Put/Call ratio: 204%
Price per share: $21.39
Number of holders: 160
Value change: +$24,271,886
Number of buys: 108
Number of sells: 68

Quarterly Holders Quick Answers

What is CUSIP G6829J107?
CUSIP G6829J107 identifies OCDX - ORTHO CLINICAL DIAGNOSTICS H - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP G6829J107:

Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021

Institutional Holders of ORTHO CLINICAL DIAGNOSTICS H - ORD SHS (OCDX) as of Q4 2021

As of 31 Dec 2021, ORTHO CLINICAL DIAGNOSTICS H - ORD SHS (OCDX) was held by 160 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 234,081,450 shares. The largest 10 holders included Carlyle Group Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Inc., JANUS HENDERSON GROUP PLC, JPMORGAN CHASE & CO, SHAPIRO CAPITAL MANAGEMENT LLC, Versor Investments LP, LAZARD ASSET MANAGEMENT LLC, and Boston Partners. This page lists 160 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.